The Future of Spatial Genomics Company Technologies: What to Expect?

09/02/2026

Consider the complex architecture of a tissue, where every cell's position tells a part of a larger functional story. For researchers seeking to read this story, the integration of spatial context with molecular data has become essential. At STOmics, we have built our mission on this need, developing a spatial multi-omics platform designed to provide comprehensive biological insights. As a focused spatial transcriptomics company, we deliver an end-to-end spatial omics service that moves discovery beyond isolated data points into a detailed spatial map.

 

The Foundation of a Complete Spatial Multi-Omics Platform

 

Our approach is built on providing a complete solution for intact tissue sections. We enable the high-precision simultaneous measurement of gene and protein expression while mapping their precise location. This integrated view is crucial for fields like oncology, neuroscience, and developmental biology, where location is inextricably linked to function. The goal of our spatial omics service is to offer researchers an unbiased discovery tool, empowering them to answer complex biological questions for both scientific research and clinical applications. This comprehensive service model defines our work as a spatial transcriptomics company.

 

Powered by Proprietary Stereo-seq Technology

 

The core of our platform's capability is Stereo-seq, our proprietary spatiotemporally enhanced resolution omics sequencing. This technology is what allows STOmics to offer a unique proposition. Stereo-seq is the only spatial technology capable of accessing the entire transcriptome at true single-cell resolution. Furthermore, with its Ultra-HD setting, it can achieve subcellular detail, and its large field-of-view options—over 160 square cm—allow for the analysis of very large tissue sections or multiple samples simultaneously. This technological edge is fundamental to the data quality we provide.

 

Demonstrated Impact and Global Scientific Collaboration

 

Since our establishment in 2020, the validation of our platform has been evidenced by its adoption and outcomes. Research utilizing our technology has been featured in several high-impact publications, including Cell, Nature, and Science. These studies underscore the practical utility of our spatial omics service in delivering novel biological insights. Beyond publications, STOmics actively forges international collaborations with academic institutions and research organizations. We are committed to advancing discoveries at a global scale, supporting the scientific community with tools that push the boundaries of what is possible in spatial biology.

 

STOmics was founded to provide a new level of clarity in biological research. By combining whole-transcriptome access with precise spatial mapping through our Stereo-seq technology, we offer a distinct spatial omics service. For researchers seeking a powerful, integrated approach, our role as a dedicated spatial transcriptomics company is to provide the complete toolkit—from chips and reagents to analysis software—that turns tissue into actionable, spatially aware data. We at STOmics are focused on enabling the next wave of discoveries through precise spatial multi-omics.